Adherence to Community-Acquired Pneumonia Guidelines in the Hospital de Clinicas Dr. Manuel Quintela in 2022

Acute Community Pneumonia is one of the most frequent infections, with high morbidity and mortality and a common reason for prescribing antimicrobials (1). The indiscriminate use of these molecules represents a public health problem due to the development of resistant microorganisms that generate their inappropriate use. In this context, Antimicrobial Optimization Programs emerge as strategies for their rational use (2). In 2018, the Hospital de Clinicas created an institutional program that implements treatment guidelines for the most prevalent infectious diseases (3). The objective of this work was to measure the adherence of prescribers to the treatment guidelines for Acute Community Pneumonia at the Hospital de Clinicas during the year 2022. A descriptive, cross-sectional and retrospective study was carried out by reviewing the electronic medical records of patients admitted in the period January-December 2022, with a diagnosis of pneumonia at hospital discharge. 130 patients were included. It is highlighted that a severity score record was found in 6% of the cases, 79% of the patients were prescribed an antimicrobial plan according to the guideline's recommendations based on the risk group and in patients who underwent microbiological studies, 86% did not show findings of diagnostic relevance. In relation to previous studies, an increase in the level of adherence to treatment guidelines was observed, particularly for the prescribed drug, maintaining a low proportion of the registration of the severity score or severity group in the clinical history, as well as a very low switch to oral route. This work shows the need for periodic audits in relation to institutional treatment guidelines.